Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...
Migraine Again on MSN
The Complete Guide to Migraine Relief: What’s New and What’s Still Tried-and-True
There are many effective acute and preventive migraine treatment options available today, including whole new medication ...
4don MSN
Study unveils mechanisms driving axonal accumulation of TDP-43 and associated nerve damage in ALS
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive muscle wasting and limb ...
Researchers from Tel Aviv University have discovered a new biological mechanism that enhances the production of myelin—a substance essential for proper brain function and nerve communication.
A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay ...
Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.
Medical Device Network on MSN
FDA clears NeurAxis’ neurostimulator for abdominal pain
The expanded FDA clearance makes NeurAxis’ IB-Stim the first FDA approval for a treatment that specifically addresses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback